229 related articles for article (PubMed ID: 1640736)
1. Induction of differentiation in Friend-erythroleukemia cells by aclacinomycin A: early transient decrease in c-myc and c-myb mRNA levels.
Schaefer A; Dressel A; Lingelbach K; Schmidt CA; Steinheider G; Marquardt H
Leukemia; 1992 Aug; 6(8):828-33. PubMed ID: 1640736
[TBL] [Abstract][Full Text] [Related]
2. DMSO-like rapid decrease in c-myc and c-myb mRNA levels and induction of differentiation in HL-60 cells by the anthracycline antitumor antibiotic aclarubicin.
Stöcker U; Schaefer A; Marquardt H
Leukemia; 1995 Jan; 9(1):146-54. PubMed ID: 7845009
[TBL] [Abstract][Full Text] [Related]
3. Calcium ionophore-induced transient down-regulation of c-myb mRNA levels in Friend erythroleukemia cells.
Schaefer A; Stöcker U; Marquardt H
J Biol Chem; 1993 May; 268(15):10876-80. PubMed ID: 8496152
[TBL] [Abstract][Full Text] [Related]
4. Regulated expression of the c-myb and c-myc oncogenes during erythroid differentiation.
Kirsch IR; Bertness V; Silver J; Hollis GF
J Cell Biochem; 1986; 32(1):11-21. PubMed ID: 3464612
[TBL] [Abstract][Full Text] [Related]
5. Protooncogene expression in normal, preleukemic, and leukemic murine erythroid cells and its relationship to differentiation and proliferation.
Robert-Lézénès J; Meneceur P; Ray D; Moreau-Gachelin F
Cancer Res; 1988 Jul; 48(14):3972-6. PubMed ID: 3164254
[TBL] [Abstract][Full Text] [Related]
6. Structure-activity relationship between anthracycline-induced differentiation and inhibition of glycoprotein synthesis in Friend erythroleukemia cells.
Schaefer A; Dahle M; Radenz G; Steinheider G; Marquardt H
Leukemia; 1991 Feb; 5(2):95-100. PubMed ID: 2020200
[TBL] [Abstract][Full Text] [Related]
7. Early transient suppression of c-myb mRNA levels and induction of differentiation in Friend erythroleukemia cells by the [Ca2+]i-increasing agents cyclopiazonic acid and thapsigargin.
Schaefer A; Magócsi M; Stöcker U; Kósa F; Marquardt H
J Biol Chem; 1994 Mar; 269(12):8786-91. PubMed ID: 8132611
[TBL] [Abstract][Full Text] [Related]
8. [Expression of protooncogenes c-myb and c-myc during the hexamethylene bisacetamide (HMBA)-induced commitment to terminal differentiation of murine erythroleukemia cells].
Chen ZX
Zhonghua Zhong Liu Za Zhi; 1991 Jul; 13(4):261-4. PubMed ID: 1806345
[TBL] [Abstract][Full Text] [Related]
9. Modulation of the c-myb, c-myc and p53 mRNA and protein levels during induced murine erythroleukemia cell differentiation.
Richon VM; Ramsay RG; Rifkind RA; Marks PA
Oncogene; 1989 Feb; 4(2):165-73. PubMed ID: 2648254
[TBL] [Abstract][Full Text] [Related]
10. Co-induction of c-fos and junB during the latent period preceding commitment of Friend erythroleukemia cells to differentiation.
Francastel C; Mazouzi Z; Robert-Lézénès J
Leukemia; 1992 Sep; 6(9):935-9. PubMed ID: 1518304
[TBL] [Abstract][Full Text] [Related]
11. A Myb dependent pathway maintains Friend murine erythroleukemia cells in an immature and proliferating state.
Chen J; Kremer CS; Bender TP
Oncogene; 2002 Mar; 21(12):1859-69. PubMed ID: 11896618
[TBL] [Abstract][Full Text] [Related]
12. The induction of Friend erythroleukaemia differentiation is markedly affected by expression of a transfected c-myb cDNA.
McMahon J; Howe KM; Watson RJ
Oncogene; 1988 Dec; 3(6):717-20. PubMed ID: 2577875
[TBL] [Abstract][Full Text] [Related]
13. c-myb effects on kinetic events during MEL cell differentiation.
Danish R; el-Awar O; Weber BL; Langmore J; Turka LA; Ryan JJ; Clarke MF
Oncogene; 1992 May; 7(5):901-7. PubMed ID: 1533276
[TBL] [Abstract][Full Text] [Related]
14. Nitric oxide-releasing agents and cGMP analogues inhibit murine erythroleukemia cell differentiation and suppress erythroid-specific gene expression: correlation with decreased DNA binding of NF-E2 and altered c-myb mRNA expression.
Suhasini M; Boss GR; Pascual FE; Pilz RB
Cell Growth Differ; 1995 Dec; 6(12):1559-66. PubMed ID: 9019161
[TBL] [Abstract][Full Text] [Related]
15. Expression of a transfected human c-myc oncogene inhibits differentiation of a mouse erythroleukaemia cell line.
Dmitrovsky E; Kuehl WM; Hollis GF; Kirsch IR; Bender TP; Segal S
Nature; 1986 Aug 21-27; 322(6081):748-50. PubMed ID: 3528861
[TBL] [Abstract][Full Text] [Related]
16. Deregulated expression of c-myc by murine erythroleukaemia cells prevents differentiation.
Prochownik EV; Kukowska J
Nature; 1986 Aug 28-Sep 3; 322(6082):848-50. PubMed ID: 3528863
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional and post-transcriptional regulation of c-myc, c-myb, and p53 during proliferation and differentiation of murine erythroleukemia cells treated with DFMO and DMSO.
Klinken SP; Holmes KL; Morse HC; Thorgeirsson SS
Exp Cell Res; 1988 Oct; 178(2):185-98. PubMed ID: 2458948
[TBL] [Abstract][Full Text] [Related]
18. Effects of ornithine decarboxylase inhibition on c-myc expression during murine erythroleukemia cell proliferation and differentiation.
Watanabe T; Sherman M; Shafman T; Iwata T; Kufe D
J Cell Physiol; 1986 Jun; 127(3):480-4. PubMed ID: 3458709
[TBL] [Abstract][Full Text] [Related]
19. Ca2+/calmodulin-dependent and -independent down-regulation of c-myb mRNA levels in erythropoietin-responsive murine erythroleukemia cells. The role of calcineurin.
Schaefer A; Magócsi M; Stöcker U; Fandrich A; Marquardt H
J Biol Chem; 1996 Jun; 271(23):13484-90. PubMed ID: 8662717
[TBL] [Abstract][Full Text] [Related]
20. Changes in gene expression during hexamethylene bisacetamide induced erythroleukemia differentiation.
Marks PA; Ramsay R; Sheffery M; Rifkind RA
Prog Clin Biol Res; 1987; 251():253-68. PubMed ID: 3481077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]